These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24841881)

  • 1. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.
    Janghorbani M; Adineh H; Amini M
    Rev Diabet Stud; 2013; 10(4):283-92. PubMed ID: 24841881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finnish Diabetes Risk Score to predict type 2 diabetes in the Isfahan diabetes prevention study.
    Janghorbani M; Adineh H; Amini M
    Diabetes Res Clin Pract; 2013 Dec; 102(3):202-9. PubMed ID: 24262944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.
    Li J; Bergmann A; Reimann M; Bornstein SR; Schwarz PE
    Horm Metab Res; 2009 Feb; 41(2):98-103. PubMed ID: 18975253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
    Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
    Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of three diabetes prediction scores in a Spanish cohort: does adding high risk for depression improve the validation of the FINDRISC score (FINDRISC-MOOD)?
    Salinero-Fort M; Mostaza-Prieto JM; Lahoz-Rallo C; Cárdenas-Valladolid J; Iriarte-Campo V; Estirado-Decabo E; Garcia-Iglesias F; Gonzalez-Alegre T; Fernandez-Puntero B; Cornejo-Del Rio VM; Sanchez-Arroyo V; Sabín-Rodríguez C; López-López S; Gómez-Campelo P; Taulero-Escalera B; Rodriguez-Artalejo F; San Andrés-Rebollo FJ; De Burgos-Lunar C;
    BMJ Open; 2024 Jun; 14(6):e083121. PubMed ID: 38844393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan.
    Tan C; Sasagawa Y; Kamo KI; Kukitsu T; Noda S; Ishikawa K; Yamauchi N; Saikawa T; Noro T; Nakamura H; Takahashi F; Sata F; Tada M; Kokai Y
    Environ Health Prev Med; 2016 Nov; 21(6):470-479. PubMed ID: 27699688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe.
    Gabriel R; Acosta T; Florez K; Anillo L; Navarro E; Boukichou N; Acosta-Reyes J; Barengo NC; Lindström J; Tuomilehto JO; Aschner P
    Diabetes Res Clin Pract; 2021 Aug; 178():108976. PubMed ID: 34302911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study.
    Janghorbani M; Amini M
    Ann Nutr Metab; 2016; 68(1):19-25. PubMed ID: 26559166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.
    Schwarz PE; Li J; Reimann M; Schutte AE; Bergmann A; Hanefeld M; Bornstein SR; Schulze J; Tuomilehto J; Lindström J
    J Clin Endocrinol Metab; 2009 Mar; 94(3):920-6. PubMed ID: 19106274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.
    Muñoz-González MC; Lima-Martínez MM; Nava A; Trerotola G; Paoli M; Cabrera-Rego JO; Gonzalez B; Arciniegas A; Paez J
    Med Princ Pract; 2019; 28(4):324-332. PubMed ID: 30852570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
    Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
    Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
    Bergmann A; Li J; Wang L; Schulze J; Bornstein SR; Schwarz PE
    Horm Metab Res; 2007 Sep; 39(9):677-82. PubMed ID: 17846976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis.
    Carvalho JA; Barengo NC; Tuomilehto J; Conceição RD; Santos RD
    Ann Med; 2011; 43(6):487-94. PubMed ID: 21604917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.
    Bernabe-Ortiz A; Perel P; Miranda JJ; Smeeth L
    Prim Care Diabetes; 2018 Dec; 12(6):517-525. PubMed ID: 30131300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neck Circumference and its Correlation to Other Anthropometric Parameters and Finnish Diabetes Risk Score (FINDRISC).
    Volaco A; Martins CM; Soares JQ; Cavalcanti AM; Moyses ST; Filho RP; Baena CP; Precoma DB
    Curr Diabetes Rev; 2018; 14(5):464-471. PubMed ID: 28969558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.
    Janghorbani M; Almasi SZ; Amini M
    Acta Diabetol; 2015 Aug; 52(4):781-8. PubMed ID: 25572334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome.
    Meijnikman AS; De Block CEM; Verrijken A; Mertens I; Van Gaal LF
    Diabetol Metab Syndr; 2018; 10():12. PubMed ID: 29507612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.